Transplantation: Alemtuzumab induction reduces acute rejection risk.
作者信息
Sidaway Peter
出版信息
Nat Rev Nephrol. 2014 Oct;10(10):542. doi: 10.1038/nrneph.2014.143. Epub 2014 Aug 12.
PMID:25112441
Abstract
摘要
相似文献
1
Transplantation: Alemtuzumab induction reduces acute rejection risk.移植：阿仑单抗诱导可降低急性排斥反应风险。
Nat Rev Nephrol. 2014 Oct;10(10):542. doi: 10.1038/nrneph.2014.143. Epub 2014 Aug 12.
2
Alemtuzumab induction therapy in kidney transplantation.
Lancet. 2014 Nov 8;384(9955):1649-51. doi: 10.1016/S0140-6736(14)61174-0. Epub 2014 Jul 28.
3
Alemtuzumab induction therapy in kidney transplantation.
Lancet. 2015 Feb 28;385(9970):770-1. doi: 10.1016/S0140-6736(15)60431-7.
4
Alemtuzumab induction therapy in kidney transplantation.
Lancet. 2015 Feb 28;385(9970):770. doi: 10.1016/S0140-6736(15)60430-5.
5
Alemtuzumab induction therapy in kidney transplantation - Authors' reply.
Lancet. 2015 Feb 28;385(9970):771. doi: 10.1016/S0140-6736(15)60432-9.
6
Alemtuzumab in kidney-transplant recipients.阿仑单抗用于肾移植受者。
N Engl J Med. 2011 Aug 18;365(7):671; author reply 671-2. doi: 10.1056/NEJMc1106937.
7
Alemtuzumab in kidney-transplant recipients.阿仑单抗用于肾移植受者。
N Engl J Med. 2011 May 19;364(20):1968-9. doi: 10.1056/NEJMe1103002.
8
Effect of alemtuzumab or basiliximab induction therapy on graft function and survival of kidneys from donors after cardiac death.阿仑单抗或巴利昔单抗诱导治疗对心脏死亡后供者肾脏移植功能及存活的影响。
Transpl Int. 2009 Oct;22(10):1024-7. doi: 10.1111/j.1432-2277.2009.00910.x. Epub 2009 Jul 13.
9
Alemtuzumab induction in renal transplantation.阿仑单抗诱导治疗肾移植。
N Engl J Med. 2011 May 19;364(20):1909-19. doi: 10.1056/NEJMoa1009546.
10
[Monoclonal antibodies in renal transplantation].
Rev Med Liege. 2009 May-Jun;64(5-6):287-92.
本文引用的文献
1
Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.基于阿仑单抗的诱导治疗与基于巴利昔单抗的诱导治疗在肾移植中的比较（3C 研究）：一项随机试验。
Lancet. 2014 Nov 8;384(9955):1684-90. doi: 10.1016/S0140-6736(14)61095-3. Epub 2014 Jul 28.
Zotero 插件